Funding for this research was provided by:
Cancer Registry of Norway Funds (-)
Text and Data Mining valid from 2018-11-08
Received: 26 June 2018
Accepted: 26 September 2018
First Online: 8 November 2018
Ethics approval and consent to participate
: The collection of iFOBT and archived samples was approved by the Regional Committees for Medical and Health Research Ethics in South-Eastern Norway (2011/1272 and 2010/3087 A, respectively). An additional ethical approval for the feasibility study was not required since all samples were anonymized and the purpose of the study was method related, as stated by the Norwegian regional ethics committee (Regional Committees for Medical and Health Research Ethics in South-Eastern Norway, ref. 2015/9).
: Not applicable.
: The authors declare that they have no competing interests, with the exception of GH received payment from Amgen Norway for giving a lecture at a medical conference in 2017.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.